Table 4.
Expression of caspase-3 in cancer cell lines after treatment with PSK for 4 days.
Tumour cell line | Expression (%) | |
Control | PSK100 μg/ml | |
AGS | 5.37% | 36.13% |
A549 | 4.20% | 31.14% |
B16 | 6.80% | 23.35% |
Ando-2 | 5.40% | 15.55% |
JURKAT | 5.35% | 6.45% |
HELA | 6.50% | 6.15% |
B9 | 3.93% | 3.74% |
This assay was repeated at least three times, producing similar results